» Articles » PMID: 1328123

New Hepatocellular Carcinoma Cell Line SUHC-1 Established from a Patient with Hepatitis C Virus RNA in Serum

Overview
Specialty Oncology
Date 1992 Aug 1
PMID 1328123
Authors
Affiliations
Soon will be listed here.
Abstract

A new human hepatocellular carcinoma cell (HCC) line, designated SUHC-1, was derived from a Japanese patient with hepatocellular carcinoma having antibody to hepatitis C virus (HCV) and HCV-RNA in his serum, and established in tissue culture. This cell line exhibited typical epithelial cell morphology in culture as observed by phase-contrast and electron microscopy. The SUHC-1 cells produced albumin and alpha 2-macroglobulin. Chromosomal analysis showed several rearrangements at short and long arms of chromosome 1, 17 and 20 (1p-, 1q-, i(1q), i(17q) and 20q+) with a modal number of 91. HCV-RNA was not detected in the supernatant of SUHC-1 cells by nested polymerase chain reaction assay or in the SUHC-1 cells by the in situ hybridization method. We concluded that complete HCV does not exist in the SUHC-1 cell line. The SUHC-1 cell line is the first line of HCC to have been derived from a patient with persistent HCV infection, and may provide a suitable model for studies of hepatocarcinogenesis related to HCV.

References
1.
Brechot C, Pourcel C, Louise A, Rain B, Tiollais P . Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature. 1980; 286(5772):533-5. DOI: 10.1038/286533a0. View

2.
Stevenson D, Lin J, Tong M, Marshall G . Characteristics of a cell line (Tong/HCC) established from a human hepatocellular carcinoma. Hepatology. 1987; 7(6):1291-5. DOI: 10.1002/hep.1840070619. View

3.
Bagnarelli P, Devescovi G, Manzin A, Bearzi I, Bonazzi P, Carloni G . Growth-factor independence of a new differentiated hepatitis B virus DNA-negative human hepatoma cell line. Hepatology. 1990; 11(6):1024-32. DOI: 10.1002/hep.1840110618. View

4.
Knowles B, HOWE C, Aden D . Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 1980; 209(4455):497-9. DOI: 10.1126/science.6248960. View

5.
Itoh Y, Iwakiri S, Kitajima K, Gotanda T, Miyaki M, Miyakawa Y . Lack of detectable reverse transcriptase activity in human and chimpanzee sera with a high infectivity for non-A, non-B hepatitis. J Gen Virol. 1986; 67 ( Pt 4):777-9. DOI: 10.1099/0022-1317-67-4-777. View